Estrella Immunopharma (ESLAW) Stock Chart & Stock Price History $0.05 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Estrella Immunopharma Stock Price Performance The Estrella Immunopharma (ESLAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 53.49%, with a year-to-date return of -45.59%. In the past month, the stock has increased 34.05%, reflecting recent market activity. As of the latest close, Estrella Immunopharma traded at $0.05 with a market cap of and volume of 2,100 shares. Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance+34.05%3 Month Performance-12.89%Year-To-Date Performance-45.59%1 Year PerformanceN/A ESLAW Stock Chart for Sunday, September, 14, 2025 ESLAW Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/12/2025$0.05$0.05$0.05$0.052,100 shs$0.0009/11/2025$0.05$0.05$0.05$0.052,100 shs$0.0009/10/2025$0.05$0.05$0.05$0.052,100 shs$0.0009/09/2025$0.05$0.05$0.05$0.0550 shs$0.0009/08/2025$0.05$0.05$0.05$0.052,169 shs$0.0009/05/2025$0.04$0.05+38.12%$0.05$0.052,169 shs$0.0009/04/2025$0.04$0.04-3.47%$0.04$0.0413,754 shs$0.0009/03/2025$0.04$0.04+4.16%$0.06$0.0423,407 shs$0.0009/02/2025$0.04$0.04$0.06$0.041,900 shs$0.0008/29/2025$0.04$0.04$0.06$0.041,900 shs$0.00 Get the Latest News and Ratings for ESLAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$0.04$0.04-15.29%$0.06$0.041,910 shs$0.0008/27/2025$0.04$0.04$0.04$0.04500 shs$0.0008/26/2025$0.04$0.04$0.04$0.04500 shs$0.0008/25/2025$0.04$0.04$0.04$0.04500 shs$0.0008/22/2025$0.04$0.04$0.04$0.04500 shs$0.0008/21/2025$0.05$0.04-14.83%$0.04$0.04540 shs$0.0008/20/2025$0.05$0.05-4.95%$0.05$0.0536,021 shs$0.0008/19/2025$0.04$0.05+17.98%$0.05$0.035,000 shs$0.0008/18/2025$0.04$0.04+10.15%$0.04$0.0431,400 shs$0.0008/15/2025$0.04$0.04+8.31%$0.04$0.043,055 shs$0.0008/14/2025$0.04$0.04-6.75%$0.04$0.04300 shs$0.0008/13/2025$0.04$0.04+7.53%$0.04$0.04350 shs$0.00 Related Companies 180 Life Sciences Stock Chart 60 Degrees Pharmaceuticals Stock Chart Alpha Tau Medical Stock Chart Apollomics Stock Chart BriaCell Therapeutics Stock Chart Cardio Diagnostics Stock Chart Celularity Stock Chart CERo Therapeutics Stock Chart Cingulate Stock Chart Clene Stock Chart Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLAW) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
